<> Brooks Laboratories Share Price Today: Live Brooks Laboratories Share Price NSE/BSE | 5paisa
BROOKS

Brooks Laboratories Share PriceBrooks Laboratories

₹102.00
-2.75 (-2.63%)
As on 05 February, 2023 | 19:52 BSE: 533543 NSE: BROOKS

Brooks Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Brooks Laboratories

Start SIP

Brooks Laboratories Share Price

  • Over 1 Month -6.21%
  • Over 3 Month -7.44%
  • Over 6 Month 20.35%
  • Over 1 Year 3.34%

Brooks Laboratories Key Statistics

P/E Ratio -10
PEG Ratio -3.5
Market Cap Cr 252
Price to Book Ratio 1.9
EPS 0.2
Dividend 0
Relative Strength Index 48.01
Money Flow Index 64.33
MACD Signal -1.86
Average True Range 5.53

Brooks Laboratories Investment Rating

  • Master Rating:
  • Brooks Laboratories has an operating revenue of Rs. 82.67 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of -26% needs improvement, ROE of -25% is poor and needs improvement. The company has a reasonable debt to equity of 15%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 15 which is a POOR score indicating inconsistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Brooks Laboratories Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 161521
Operating Expenses Qtr Cr 161921
Operating Profit Qtr Cr 0-40
Depreciation Qtr Cr 000
Interest Qtr Cr 000
Tax Qtr Cr 000
Net Profit Qtr Cr -1-50

Brooks Laboratories Technicals

EMA & SMA

Current Price
₹102.
-2.75 (-2.63%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • 103.32
  • 50 Day
  • 106.04
  • 100 Day
  • 106.65
  • 200 Day
  • 104.19
  • 20 Day
  • 101.84
  • 50 Day
  • 108.57
  • 100 Day
  • 110.17
  • 200 Day
  • 101.27

Brooks Laboratories Resistance and Support

PIVOT
₹106.67
Resistance
First Resistance 109.19
Second Resistance 113.62
Third Resistance 116.14
RSI 48.01
MFI 64.33
MACD Single Line -1.86
MACD -0.99
Support
First Resistance 102.24
Second Resistance 99.72
Third Resistance 95.29

Brooks Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 55,334 3,350,474 60.55
Week 55,375 3,406,658 61.52
1 Month 33,564 2,195,101 65.4
6 Month 39,232 3,475,593 88.59

Brooks Laboratories Result Highlights

Brooks Laboratories Synopsis

NSE-Medical-Generic Drugs

Brooks Laboratories is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 76.97 Cr. and Equity Capital is Rs. 24.70 Cr. for the Year ended 31/03/2022. Brooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267.
Market Cap 254
Sales 70
Shares in Float 0.84
No of funds 2
Yield
Book Value 3.9
U/D Vol ratio 0.8
LTDebt / Equity 2
Alpha 0.07
Beta 0.98

Brooks Laboratories

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 66.41%66.41%66.41%
Foreign Portfolio Investors
Individual Investors 27.8%28.19%28.75%
Others 5.79%5.4%4.84%

Brooks Laboratories Management

Name Designation
Mr. Atul Ranchal Chairman
Mr. Rajesh Mahajan Managing Director
Mr. Manpreet Singh Naroo Director - Technical
Ms. Sonia Gupta Independent Director
Mr. Deepak Mahajan Independent Director
Mr. Rajnish Kumar Bedi Independent Director

Brooks Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Brooks Laboratories Corporate Action

Date Purpose Remarks
2023-02-14 Quarterly Results
2023-01-25 Rights issue of Equity Shares
2022-11-14 Quarterly Results
2022-08-10 Quarterly Results
2022-05-30 Audited Results

Brooks Laboratories FAQs

What is Share Price of Brooks Laboratories ?

Brooks Laboratories share price is ₹102 As on 05 February, 2023 | 19:38

What is the Market Cap of Brooks Laboratories ?

The Market Cap of Brooks Laboratories is ₹252 Cr As on 05 February, 2023 | 19:38

What is the P/E ratio of Brooks Laboratories ?

The P/E ratio of Brooks Laboratories is -10 As on 05 February, 2023 | 19:38

What is the PB ratio of Brooks Laboratories ?

The PB ratio of Brooks Laboratories is 1.9 As on 05 February, 2023 | 19:38

Q2FY23